Nishadil
Ads Astrology Calendar Devs Domains Finance Pay Rewards Weather
Signup Signin
Washington | 13°C (few clouds)
Topic Feed

PharmaceuticalMarket

Showing the latest stories and updates for this topic.
The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun
A Boost for Skin Health: Zydus Lifesciences Secures Key USFDA Approval

A Boost for Skin Health: Zydus Lifesciences Secures Key USFDA Approval
Waters Stock Takes a Hit After Strong Q4, Blames Murky 2024 Forecast

Waters Stock Takes a Hit After Strong Q4, Blames Murky 2024 Forecast
A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift

A Tale of Two Pivots: Hims & Hers Retreats on Weight-Loss Pill, Washington Post Sees Editorial Shift
Hims & Hers Hits the Brakes: Generic Wegovy Plans Abandoned Amidst GLP-1 Market Shifts

Hims & Hers Hits the Brakes: Generic Wegovy Plans Abandoned Amidst GLP-1 Market Shifts
A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions

A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions
Ironwood Pharmaceuticals Shares Surge as Ambitious 2026 Outlook Ignites Investor Confidence

Ironwood Pharmaceuticals Shares Surge as Ambitious 2026 Outlook Ignites Investor Confidence
Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up

Wegovy's Reckoning: Novo Nordisk's CEO Digs In as the Weight Loss Market Heats Up
The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market
The Pharmaceutical Reckoning: How Weight Loss Breakthroughs Are Rewriting the Rules, One Pill (or Shot) at a Time

The Pharmaceutical Reckoning: How Weight Loss Breakthroughs Are Rewriting the Rules, One Pill (or Shot) at a Time
Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave

Unpacking Biopharma's Wild Ride: Fast Money's Hot Takes on Navigating the Next Wave
India's Weighty Dilemma: Lupin Pharma's Billion-Dollar Bet on Battling the Bulge

India's Weighty Dilemma: Lupin Pharma's Billion-Dollar Bet on Battling the Bulge
A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief
Rewriting the Rules: How Tiny Molecules Are Unlocking a Giant Future for Medicine

Rewriting the Rules: How Tiny Molecules Are Unlocking a Giant Future for Medicine
CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough

CAR-T's Tightrope Walk: Why Autolus Faces an Uphill Battle Despite a Breakthrough
The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal

The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal
A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake
The Pharmaceutical Sector Set to Soar: A Path to $3.03 Trillion by 2034

The Pharmaceutical Sector Set to Soar: A Path to $3.03 Trillion by 2034
The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment

The Next Frontier: Eli Lilly and Novo Nordisk Gear Up for a Revolution in Oral Obesity Treatment
A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle

A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle
Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta

Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta
Global Leuprolide Acetate Market Poised for Significant Growth, Projected to Hit USD 4.43 Billion by 2032 as Hormone Therapy Demand Surges

Global Leuprolide Acetate Market Poised for Significant Growth, Projected to Hit USD 4.43 Billion by 2032 as Hormone Therapy Demand Surges
Lung Cancer Therapeutics Market Set to Soar Beyond $61 Billion by 2032: A New Horizon Driven by Precision Medicine and Immunotherapies

Lung Cancer Therapeutics Market Set to Soar Beyond $61 Billion by 2032: A New Horizon Driven by Precision Medicine and Immunotherapies
Antiemetics Drugs Market Set to Skyrocket to $11.69 Billion by 2032: A Deep Dive into Growth Drivers and Breakthrough Innovations

Antiemetics Drugs Market Set to Skyrocket to $11.69 Billion by 2032: A Deep Dive into Growth Drivers and Breakthrough Innovations
Fuelling Hope: Breakthroughs Propel Dementia Treatment Market Towards a Staggering $33.54 Billion Future

Fuelling Hope: Breakthroughs Propel Dementia Treatment Market Towards a Staggering $33.54 Billion Future
The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?
The Autoimmune Revolution: IL-23 Inhibitors Poised for Massive Market Growth

The Autoimmune Revolution: IL-23 Inhibitors Poised for Massive Market Growth
Load more..